Telepharmacy module in clinical pharmacy clerkship Drug-related problem assessment and student reflections

• Published in: PHARMACY EDUCATION
• Main Authors: Karuppannan, Mahmathi; Hamdan, Nor Elyzatul Akma; Usir, Ezlina; Saman, Kamaliah Md.; Said, Siti Norlina Md.; Zulkifly, Hanis Hanum; Zaki, Izzati Abdul Halim; Noordin, Zakiah Mohd
• Format: Article
• Language: English
• Published: INTERNATIONAL PHARMACEUTICAL FEDERATION 2024
• Subjects: Education & Educational Research
• Online Access: https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001327390700001
• ISSN: 1560-2214; 1477-2701
• DOI: 10.46542/pe.2024.241.562571

Background: Telepharmacy services received much attention during the COVID-19 pandemic. These services have proven to be a valuable tool in providing remote patient care and ensuring medication safety. However, there is limited research on assessing drug-related problems (DRPs) and the impact of telepharmacy on student learning and reflection. Objective: To characterise the types of DRPs identified and reflect on students' telepharmacy modules during final-year clerkship experiences. Methods: In groups of three to five, final-year students conducted 30-minute telepharmacy sessions, documenting patient details and DRPs on data collection forms under supervision. The data were analysed descriptively, and students' reflections were collected via a Google Form survey. Results: A total of 187 students completed 48 medication use reviews via telepharmacy. Forty-eight patients were reviewed and 122 DRPs were identified. The average age was 56 years and they were taking an average of five medications. The most common types of DRPs reported during telepharmacy sessions were non-compliance (n=42) and adverse drug reactions (ADR) (n=30). The main challenges identified by the students throughout the telepharmacy session were unforeseen inquiries and patients with information recall issues. Conclusion: Under the guidance of their lecturers, pharmacy students identified a significant number of DRPs through telepharmacy medication use review activities.